hepatitis-c-virus

Documents about hepatitis-c-virus

• Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.#811833ClinicalTrials.gov
• Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)#838415ClinicalTrials.gov
• Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection#860945ClinicalTrials.gov
• A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection#891331ClinicalTrials.gov
• Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy#869028ClinicalTrials.gov
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection#873623ClinicalTrials.gov
• An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients#884636ClinicalTrials.gov
• Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects#877395ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis#855943ClinicalTrials.gov
• Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)#865965ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection#889282ClinicalTrials.gov
• Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)#906228ClinicalTrials.gov
• Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta-analysis.#281630Repisalud
• Elimination of Hepatitis C Virus Among Users of Substances#854725ClinicalTrials.gov
• Pharmacist-led Hepatitis C Management#859889ClinicalTrials.gov
• Re-treatment of HCV Following DAA Failure#867097ClinicalTrials.gov
• Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)#894840ClinicalTrials.gov
• Recently acquired hepatitis C: Epidemiological characteristics and treatment response in a large cohort of MSM living with HIV in Madrid.#276168Repisalud
• Facilitated Telemedicine for Underserved Populations: Management of Chronic Hepatitis C Virus Infection. The TEAM-C Study#468655NCBI Bookshelf
• Hepatitis c virus infection risk tool for patients with cancer#1039226IRIS
• A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use#830456ClinicalTrials.gov
• Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting#917189ClinicalTrials.gov
• Fabrication and Development of a Microfluidic Paper-Based Immunosorbent Assay Platform (μpisa) for Colorimetric Detection of Hepatitis C#1027218İzmir Yüksek Teknoloji Enstitüsü
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease#800816ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection#904136ClinicalTrials.gov
• Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients#917834ClinicalTrials.gov
• Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."#891973ClinicalTrials.gov
• Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus#121923HAL (France)
• Digital Community to Improve Health in Rural Areas#174951ClinicalTrials.gov
• Patient-Centered Hepatitis C Virus Care for People Who Inject Drugs—The HERO Study#213679NCBI Bookshelf
• Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection: web annex 6: decision-making table, PICO question on children and adolescents#403684WHO IRIS
• The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection#828458ClinicalTrials.gov
• Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C#866691ClinicalTrials.gov
• A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection#901612ClinicalTrials.gov
• Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies#981380ClinicalTrials.gov
• A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)#905855ClinicalTrials.gov
• Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy#831051ClinicalTrials.gov
• Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).#993944ClinicalTrials.gov
• Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population#827256ClinicalTrials.gov
• A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)#859024ClinicalTrials.gov
• Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection#880494ClinicalTrials.gov
• Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I#908348ClinicalTrials.gov
• PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a)#913152ClinicalTrials.gov
• An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus#856004ClinicalTrials.gov
• Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients#829722ClinicalTrials.gov
• Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia#837993ClinicalTrials.gov
• A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures#863509ClinicalTrials.gov
• Evaluating Pay-It-Forward Strategy to Promote Hepatitis B Virus and Hepatitis C Virus Testing Among International Migrants From Low- and Middle-Income Countries in China: Protocol for a Cluster Randomized Controlled Trial.#219143NCBI PubMed Central
• A retrospective cohort data-linkage study of secondary healthcare use prior to late blood-borne virus diagnosis in Scotland – A missed opportunity for earlier diagnosis?#990058STORRE
• Seroprevalence of hepatitis C virus among refugees, asylum seekers, and internally displaced populations within Africa: A systematic review and meta-analysis.#9857PubMed